Axogen Inc vs ProShares Ultra QQQ ETF — how do they compare? Axogen Inc trades at $48.51 (market cap $2.61B), while ProShares Ultra QQQ ETF trades at $93.04. The key difference: Axogen Inc is trading nearer its 52-week high, ProShares Ultra QQQ ETF nearer its low. Which is the better fit depends on your goals.
| AXGN | QLD | |
|---|---|---|
Market Cap | $2.61B | — |
Sector | Technology | Leveraged / Inverse |
52-Week High | $48.48 | $100.53 |
52-Week Low | $14.16 | $57.16 |
Enterprise Value | $2.52B | — |
Trailing returns across standard periods
Axogen is a leader in peripheral nerve regeneration and repair. It provides innovative surgical solutions and clinically proven products, like nerve grafts, to help restore function and quality of life for patients.
Read more on AXGN →QLD is a leveraged ETF that seeks daily investment results corresponding to 200% of the daily performance of the NASDAQ-100 Index. It achieves 2x leverage by investing in financial instruments such as swaps and is designed as a tactical trading tool for investors with a bullish (long) view on the NASDAQ-100. Due to the effects of compounding and leverage, the ETF is intended to be held for a single day and is not suitable for long-term investment.
Read more on QLD →